These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 19231456)
1. Is pneumonectomy justified in patients with locally advanced NSCLC and persistent N2 disease after induction chemotherapy? Klomp HM; Kappers I Ann Thorac Surg; 2009 Mar; 87(3):990-1. PubMed ID: 19231456 [No Abstract] [Full Text] [Related]
7. Pneumonectomy after induction radiochemotherapy: is it time for a meta-analysis? Cusumano G; Cesario A; Margaritora S J Thorac Cardiovasc Surg; 2010 Mar; 139(3):806-7; author reply 807. PubMed ID: 20176239 [No Abstract] [Full Text] [Related]
8. [On ''Multimodal treatment of clinical non-small cell N2 bronchogenic carcinoma: what is the answer?'']. González Aragoneses F Arch Bronconeumol; 2007 Mar; 43(3):183-4; author reply 184. PubMed ID: 17386198 [No Abstract] [Full Text] [Related]
10. Pulmonary resection after concurrent chemotherapy and high dose (60Gy) radiation for non-small cell lung cancer is safe and may provide increased survival. Cerfolio RJ; Bryant AS; Jones VL; Cerfolio RM Eur J Cardiothorac Surg; 2009 Apr; 35(4):718-23; discussion 723. PubMed ID: 19233668 [TBL] [Abstract][Full Text] [Related]
11. Surgery after induction chemoradiotherapy for non small cell lung cancer: when and why. Koletsis EN; Prokakis C; Apostolakis E; Chatzimichalis A; Dougenis D J BUON; 2007; 12(4):453-61. PubMed ID: 18067202 [TBL] [Abstract][Full Text] [Related]
13. [Clinical investigation of weekly Carboplatin and Paclitaxel with concurrent radiation therapy for locally advanced non-small cell lung cancer]. Mito A; Yamasaki M; Matsuura K; Kajihara T; Nitta T; Awaya H; Arita K; Kashiwado K; Ohashi N Gan To Kagaku Ryoho; 2009 Oct; 36(10):1653-6. PubMed ID: 19838022 [TBL] [Abstract][Full Text] [Related]
14. The incidence of perioperative anastomotic complications after sleeve lobectomy is not increased after neoadjuvant chemoradiotherapy. Milman S; Kim AW; Warren WH; Liptay MJ; Miller C; Basu S; Faber LP Ann Thorac Surg; 2009 Sep; 88(3):945-50; discussion 950-1. PubMed ID: 19699925 [TBL] [Abstract][Full Text] [Related]
17. [Stage III NSCLC. The surgeon's role in exploration and treatment]. van Schil P; de Waele M; Hendriks J; Lauwers P Rev Mal Respir; 2008 Oct; 25(8 Pt 2):3S88-94. PubMed ID: 18971831 [TBL] [Abstract][Full Text] [Related]
18. Is pneumonectomy a justified procedure in patients with persistent N2 nonsmall cell lung cancer disease following induction therapy. Mitsos S; Petko M; Patrini D; Hayward M; Scarci M; Lawrence D; Panagiotopoulos N Indian J Cancer; 2017; 54(1):73-81. PubMed ID: 29199668 [TBL] [Abstract][Full Text] [Related]
19. [Differential indications for induction therapy of non-small-cell lung tumors]. Drings P; Manegold C Chirurg; 2000 Dec; 71(12):1466-73. PubMed ID: 11195065 [TBL] [Abstract][Full Text] [Related]